{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:57:14Z","timestamp":1790402234499,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006436","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T13:26:57Z","timestamp":1547645217000},"page":"e0006436","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Flubendazole as a macrofilaricide: History and background"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3229-0239","authenticated-orcid":true,"given":"Timothy G.","family":"Geary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4939-6996","authenticated-orcid":true,"given":"Charles D.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Silber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40249-016-0147-4","article-title":"The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000\u20132014)","volume":"5","author":"HC Turner","year":"2016","journal-title":"Infectious Diseases of Poverty"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e0003703","DOI":"10.1371\/journal.pntd.0003703","article-title":"The contributions of onchocerciasis control and elimination programs toward the achievement of the Millennium Development Goals","volume":"9","author":"C Dunn","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","article-title":"Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for <italic>Loa loa<\/italic> infection","volume":"350","author":"J Gardon","year":"1997","journal-title":"Lancet"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1475-2883-2-S1-S10","article-title":"Programmatic and communication issues in relation to serious adverse events following ivermectin treatment in areas co-endemic for onchocerciasis and loiasis","volume":"2","author":"NJ Haselow","year":"2003","journal-title":"Filaria Journal"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/eri.11.76","article-title":"Progress and challenges in the discovery of macrofilaricidal drugs","volume":"9","author":"TG Geary","year":"2011","journal-title":"Expert Review of Anti-infective Therapy"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/QCO.0b013e328359f04a","article-title":"Are new anthelmintics needed to eliminate human helminthiases?","volume":"25","author":"T.G. Geary","year":"2012","journal-title":"Current Opinion in Infectious Diseases"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpddr.2016.04.002","article-title":"Research for new drugs for elimination of onchocerciasis in Africa","volume":"6","author":"AC Kuesel","year":"2016","journal-title":"International Journal for Parasitology\u2014Drugs and Drug Resistance"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"MJ Taylor","year":"2010","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0031182013001108","article-title":"Anti-<italic>Wolbachia<\/italic> drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis","volume":"141","author":"MJ Taylor","year":"2014","journal-title":"Parasitology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/civ882","article-title":"Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of Bancroftian filariasis","volume":"62","author":"EK Thomsen","year":"2016","journal-title":"Clinical Infectious Diseases"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e0005163","DOI":"10.1371\/journal.pntd.0005163","article-title":"Potential value of triple drug therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic filariasis and onchocerciasis in Africa","volume":"11","author":"PU Fischer","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e0003534","DOI":"10.1371\/journal.pntd.0003534","article-title":"Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis","volume":"9","author":"CA Bulman","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/infdis\/jiv065","article-title":"Targeting filarial Abl-like kinases: Orally available, Food and Drug Administration-approved tyrosine kinase inhibitors are microfilaricidal and macrofilaricidal","volume":"212","author":"EM O\u2019Connell","year":"2015","journal-title":"Journal of Infectious Diseases"},{"key":"ref14","unstructured":"Drugs for Neglected Diseases initiative. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.dndi.org\/diseases-projects\/filarial-diseases\/filaria-portfolio\/\" xlink:type=\"simple\">https:\/\/www.dndi.org\/diseases-projects\/filarial-diseases\/filaria-portfolio\/<\/ext-link>. [cited 2017 October 2]."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41598-017-00322-5","article-title":"Short-course, high-dose rifampicin achieves Wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis","volume":"7","author":"G Aljayyoussi","year":"2017","journal-title":"Scientific Reports"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1586\/eri.11.30","article-title":"Flubendazole, a potentially valuable macrofilaricide for lymphatic filariasis and onchocerciasis field programs","volume":"9","author":"C.D. Mackenzie","year":"2011","journal-title":"Expert Review of Anti- infective Therapy"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(83)92753-8","article-title":"Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis","volume":"321","author":"A Dominguez-Vazquez","year":"1983","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e0002838","DOI":"10.1371\/journal.pntd.0002838","article-title":"Exploring the potential of flubendazole in filariasis control: evaluation of the systemic exposure for different pharmaceutical preparations","volume":"8","author":"L Ceballos","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.reprotox.2014.06.009","article-title":"<italic>In vivo<\/italic> preliminary investigations of the effects of the benzimidazole anthelmintic drug flubendazole on rat embryos and fetuses","volume":"49","author":"M Longo","year":"2014","journal-title":"Reproductive Toxicology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/mutage\/gev070","article-title":"Genotoxicity of flubendazole and its metabolites <italic>in vitro<\/italic> and the impact of a new formulation on in vivo aneugenicity","volume":"31","author":"DJ Tweats","year":"2016","journal-title":"Mutagenesis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.xphs.2016.03.003","article-title":"Evaluation of three amorphous drug delivery technologies to improve the oral absorption of flubendazole","volume":"105","author":"M Vialpando","year":"2016","journal-title":"Journal of Pharmaceutical Science"},{"key":"ref22","article-title":"Toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk\/benefit to patients","author":"S Lachau-Durand","journal-title":"PLoS Negl Trop Dis, in press"},{"key":"ref23","article-title":"Efficacy of single and repeated oral and subcutaneous doses of flubendzole in Litomosoides sigmodontis infected jirds","author":"MP H\u00fcbner","journal-title":"PLoS Negl Trop Dis, in press"},{"key":"ref24","article-title":"Efficacy of single and repeated oral and subcutaneous doses of fllubendazole in male jirds (Meriones unguiculatus) ingected with the filarial nematode Brugia pahangi","author":"C Bidlow","journal-title":"PLoS Negl Trop Dis, in press"},{"key":"ref25","article-title":"Oral dose flubendazole does not mediate significant macrofilaricidal or microfilaricidal activities against Onchocerca adult or Brugia microfilarie in a pan-filarial SCID mouse infection model","author":"H Sjoberg","journal-title":"PLoS Negl Trop Dis, in press"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpddr.2015.06.002","article-title":"In vitro flubendazole- induced damage to vital tissues in adult females of the filarial nematode <italic>Brugia malayi<\/italic>","volume":"5","author":"M O\u2019Neill","year":"2015","journal-title":"International Journal of Parasitology\u2014Drugs and Drug Resistance"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e0004698","DOI":"10.1371\/journal.pntd.0004698","article-title":"An <italic>in vitro\/in vivo<\/italic> model to analyze the effects of flubendazole exposure on adult female <italic>Brugia malayi<\/italic>","volume":"10","author":"M O\u2019Neill","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijpddr.2016.09.005","article-title":"Profiling the macrofilaricidal effects of flubendazole on adult female <italic>Brugia malayi<\/italic> using RNAseq","volume":"6","author":"M O\u2019Neill","year":"2016","journal-title":"International Journal for Parasitology\u2014Drugs and Drug Resistance"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4269\/ajtmh.17-0390","article-title":"Potential role for flubendazole in limiting filariasis transmission: observations of microfilarial sensitivity","volume":"98","author":"M O\u2019Neill","year":"2018","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/jvp.12383","article-title":"Species differences in hepatic biotransformation of the anthelmintic drug flubendazole","volume":"40","author":"ML Mat\u00e9","year":"2017","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2012.12.004","article-title":"Effects of the benzimidazole anthelmintic drug flubendazole on rat embryos <italic>in vitro<\/italic>","volume":"36","author":"M Longo","year":"2013","journal-title":"Reproductive Toxicology"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T04:26:44Z","timestamp":1588998404000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006436"}},"subtitle":[],"editor":[{"given":"Sara","family":"Lustigman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006436","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]}}}